REQUEST A DEMO
Total
USD $0.00
Search more companies

Unimed Pharma, spol. s r.o. (Slovakia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Unimed Pharma, spol. s r.o. Profile Updated: January 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Unimed Pharma, spol. s r.o. is an enterprise based in Slovakia. Its main office is in Bratislava. It operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on February 16, 1994. There are currently 50 - 99 (2023) people employed by Unimed Pharma, spol. s r.o.. The latest financial highlights indicate a net sales revenue increase of 12.18% in 2022. Its’ total assets recorded a growth of 5.23%. In 2022, Unimed Pharma, spol. s r.o.’s net profit margin decreased by 6.17%.

Headquarters
Orieskova 11
Bratislava; Bratislavsky; Postal Code: 82105

Contact Details: Purchase the Unimed Pharma, spol. s r.o. report to view the information.

Basic Information
Total Employees:
Purchase the Unimed Pharma, spol. s r.o. report to view the information.
Outstanding Shares:
Purchase the Unimed Pharma, spol. s r.o. report to view the information.
Registered Capital:
Purchase the Unimed Pharma, spol. s r.o. report to view the information.
Incorporation Date:
February 16, 1994
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Unimed Pharma, spol. s r.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
12.18%
Total operating revenue
11.95%
Operating profit (EBIT)
-34.6%
EBITDA
-28.54%
Net Profit (Loss) for the Period
-59.62%
Total assets
5.23%
Total equity
2.82%
Operating Profit Margin (ROS)
-6.94%
Net Profit Margin
-6.17%
Return on Equity (ROE)
-4.25%
Debt to Equity Ratio
0%
Quick Ratio
-6.5%
Cash Ratio
-6.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?